Stroke and neuroinflamation: Role of sexual hormones

Current Pharmaceutical Design

Volumn 22, Issue 10, 2016, Pages 1334-1349

  Perez Alvarez, Maria Jose ^a,b,c   Wandosell, Francisco ^b,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Estradiol; Glia; Neuroinflammation; Neuroprotection; OGD; Progesterone; Stroke

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ESTRADIOL; PROGESTERONE; SEX HORMONE; ANTIINFLAMMATORY AGENT; NEUROPROTECTIVE AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BLOOD CELL; BRAIN CELL; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; INFLAMMATORY CELL; LEUKOCYTE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; DRUG EFFECTS; FEMALE; INFLAMMATION; MALE; NEURODEGENERATIVE DISEASES; STROKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFLAMMATION; MALE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; STROKE;

EID: 84961696470     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161282210160304112834     Document Type: Article

References (301)

1. Nilupul Perera M, Ma HK, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci 2006; 13: 1-8
2. Najjar S, Pearlman D, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflamm 2013; 10: 43
3. Arevalo MA, Santos-Galindo M, Acaz-Fonseca E, Azcoitia I, Garcia-Segura LM. Gonadal hormones and the control of reactive gliosis. Horm Behav 2013; 63: 216-21
4. Estes ML, MCAllister AK. Alterations in immune cells and mediators in the brain: It's not always neuroinflammation!. Brain Pathol 2014; 24: 623-30
5. Block F, Dihné M. Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 2005; 75: 342-65
6. Lucas S-M, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147: S232-40
7. Hallenbeck J. Significance of the inflammatory response in brain ischemia. In: Baethmann A, Kempski O, Plesnila N, Staub F, Eds. Mechanisms of Secondary Brain Damage in Cerebral Ischemia and Trauma. Vienna: Springer 1996; pp. 27-31
8. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007; 184: 53-68
9. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics 2013. Update a report from the american heart association. Circulation 2013; 127: e6-245
10. Lenglet S, Montecucco F, Denes A, et al. Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice. J Cereb Blood Flow Metab 2014; 34: 802-12
11. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-703
12. Pérez-Alvarez MJ, Wandosell F. Estradiol in CNS: role in neurodegeneration. In: Palmeri R, Grimaudo S, eds., Estradiol: synthesis, health effects and drug interaction. New York: Nova Science Publishers 2013; p. 39
13. Casals JB, Pieri NCG, Feitosa MLT, et al. The use of animal models for stroke research: A review. Comp Med 2011; 61: 305-13
14. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87: 179-97
15. Green RA, Odergren T, Ashwood T. Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 2003; 24: 402-408
16. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-7
17. Wu L, Zhang K, Hu G, Yan H, Xie C, Wu X. Inflammatory response and neuronal necrosis in rats with cerebral ischemia. Neural Regeneration Res 2014; 9: 1753-62
18. Denes A, Thornton P, Rothwell NJ, Allan SM. Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010; 24: 708-23
19. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66: 232-45
20. Huang P, Zhou C-M, Qin H, et al. Cerebralcare Granule® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats. Exp Neurol 2012; 237: 453-63
21. Kriz J. Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol 2006; 18: 145-57
22. Huang L WZ, ZhuGe Q, Zheng W, et al. Glial scar formation occurs in the human brain after ischemic stroke. Int J Med Sci 2014; 11(4): 344-8
23. Thomas WE. Brain macrophages: evaluation of microglia and their functions. Brain Res Rev 1992; 17: 61-74
24. Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of Microglia. Physiol Rev 2011; 91: 461-553
25. Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist 2015; 21(2): 169-84
26. Graeber M, Streit W. Microglia: biology and pathology. Acta Neuropathol 2010; 119: 89-105
27. Suh H-S, Zhao M-L, Derico L, Choi N, Lee S. Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J Neuroinflamm 2013; 10: 37-49
28. Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learningdependent synapse formation through BDNF. Cell 2013; 155: 1596-609
29. Morioka T, Kalehua AN, Streit WJ. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993; 327: 123-32
30. Perez-Alvarez M, Maza Md, Anton M, Ordonez L, Wandosell F. Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J Neuroinflamm 2012; 9: 157-70
31. Yrjänheikki J, Keinänen R, Pellikka M, Hökfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998; 95: 15769-74
32. Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-9
33. Watanabe H, Abe H, Takeuchi S, Tanaka R. Protective effect of microglial conditioning medium on neuronal damage induced by glutamate. Neurosci Lett 2000; 289: 53-6
34. Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol 2014; 10: 217-24
35. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord. J Neurosci 2009; 29(43): 13435-44
36. Shao Y, Deng T, Zhang T, Li P, Wang Y. FAM19A3, a novel secreted protein, modulates the microglia/macrophage polarization dynamics and ameliorates cerebral ischemia. FEBS Lett 2015; 589: 467-75
37. Durafourt BA, Moore CS, Zammit DA, et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012; 60: 717-27
38. Hu X, Li P, Guo Y, et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 2012; 43: 3063-70
39. Wang G, Zhang J, Hu X, et al. Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab 2013; 33: 1864-74
40. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005; 50: 427-34
41. Rabchevsky AG, Weinitz JM, Coulpier M, Fages C, Tinel M, Junier MP. A role for transforming growth factor as an inducer of astrogliosis. J Neurosci 1998; 18: 10541-10552
42. Klein MA, Möller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 1997; 19: 227-33
43. Winter CG, Saotome Y, Levison SW, Hirsh D. A role for ciliary neurotrophic factor as an inducer of reactive gliosis, the glial response to central nervous system injury. Proc Natl Acad Sci USA 1995; 92: 5865-9
44. Dong Y, Benveniste EN. Immune function of astrocytes. Glia 2001; 36: 180-90
45. Hewett SJ, Muir JK, Lobner D, Symons A, Choi DW. Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS. Stroke 1996; 27: 1586-91
46. Bush TG, Puvanachandra N, Horner CH, et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999; 23: 297-308
47. Sofroniew MV, Bush TG, Blumauer N, Lawrence K, Mucke L, Johnson HM. Genetically-targeted and conditionally-regulated ablation of astroglial cells in the central, enteric and peripheral nervous systems in adult transgenic mice1. Brain Res 1999; 835: 91-5
48. Yoshikawa A, Kamide T, Hashida K, et al. Deletion of Atf6 impairs astroglial activation and enhances neuronal death following brain ischemia in mice. J Neurochem 2015; 132: 342-53
49. Li L, Lundkvist A, Andersson D, et al. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2007; 28: 468-81
50. de Pablo Y, Nilsson M, Pekna M, Pekny M. Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion. Histochem Cell Biol 2013; 140: 81-91
51. Chuaqui R, Tapia J. Histologic Assessment of the Age of Recent Brain Infarcts in Man. J Neuropathol Exp Neurol 1993; 52: 481-9
52. Mena H, Cadavid D, Rushing E. Human cerebral infarct: a proposed histopathologic classification based on 137 cases. Acta Neuropathol 2004; 108: 524-30
53. Emsley HCA, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003; 139: 93-101
54. Buck BH, Liebeskind DS, Saver JL, et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 2008; 39: 355-60
55. Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RF. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 1994; 34: 137-41
56. Mackay KB, Bailey SJ, King PD, Patel S, Hamilton TC, Campbell CA. Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat. Neurodegeneration 1996; 5(4): 319-23
57. Hartl R, Schurer L, Schmid-Schonbein GW, del Zoppo GJ. Experimental Antileukocyte Interventions in Cerebral Ischemia. J Cereb Blood Flow Metab 1996; 16: 1108-19
58. Blann A, Kumar P, Krupinski J, McCollum C, Beevers DG, Lip GYH. Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke. Blood Coagul Fibrinol 1999; 10: 277-84
59. Lindsberg PJ, Carpe´n O, Paetau A, Karjalainen-Lindsberg M-L, Kaste M. Endothelial ICAM-1 Expression Associated With Inflammatory Cell Response in Human Ischemic Stroke. Circulation 1996; 94: 939-45
60. Roy S, Das S, Danaboina R, et al. Association of E-selectin gene polymorphism (S128R) with ischemic stroke and stroke subtypes. Inflammation 2014; 37: 599-603
61. Prugger C, Luc G, Haas B, et al. Multiple Biomarkers for the Prediction of Ischemic Stroke: The PRIME Study. Arterioscler, Thromb, Vasc Biol 2013; 33: 659-66
62. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 1993; 74: 541-54
63. Huang J, Choudhri TF, Winfree CJ, et al. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 2000; 31: 3047-53
64. Ma X-J, Cheng J-W, Zhang J, et al. E-selectin deficiency attenuates brain ischemia in mice. CNS Neurosci Ther 2012; 18: 903-8
65. Mocco J, Choudhri T, Huang J, et al. HuEP5C7 as a humanized monoclonal Anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circulation Res 2002; 91: 907-14
66. Bowes MP, Zivin JA, Rothlein R. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 1993; 119: 215-9
67. Zhang RL, Chopp M, Jiang N, et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the wistar rat. Stroke 1995; 26: 1438-43
68. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo J-M, Ford GA, Investigators ftAS. Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279, 276 in acute ischemic stroke. Stroke 2003; 34: 2543-8
69. Chen Y, Hallenbeck JM, Ruetzler C, et al. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab 2003; 23: 748-55
70. Stamatovic SM, Shakui P, Keep RF, et al. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 2005; 25: 593-606
71. Soriano SG, Amaravadi LS, Wang YF, et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 2002; 125: 59-65
72. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012; 32: 1677-98
73. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1 and IL-1 in Ischemic Brain Damage. J Neurosci 2001; 21: 5528-34
74. Galea J, Brough D. The role of inflammation and interleukin-1 in acute cerebrovascular disease. J Inflamm Res 2013; 6: 121-8
75. Touzani O, Boutin H, LeFeuvre R, et al. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 2002; 22: 38-43
76. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ. The progression and topographic distribution of interleukin-1[beta] expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1999; 19: 87-98
77. Amantea D, Certo M, Russo R, Bagetta G, Corasaniti MT, Tassorelli C. Early reperfusion injury is associated to MMP2 and IL-1 elevation in cortical neurons of rats subjected to middle cerebral artery occlusion. Neuroscience 2014; 277: 755-63
78. Brough D, Tyrrell PJ, Allan SM. Regulation of interleukin-1 in acute brain injury. Trends Pharmacol Sci 2011; 32: 617-22
79. Emsley HCA, Smith CJ, Georgiou RF, et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 2005; 76: 1366-72
80. Helmy A, Guilfoyle MR, Carpenter KLH, Pickard JD, Menon DK, Hutchinson PJ. Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial. J Cereb Blood Flow Metab 2014; 34: 845-51
81. Singh N, Hopkins S, Hulme S, et al. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J Neuroinflamm 2014; 11: 1-8
82. Yamashita T, Sawamoto K, Suzuki S, et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 2005; 94: 459-68
83. Yan J, Greer JM, McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual variability. J Neuroimmunol 2012; 246: 78-84
84. Patzer A, Zhao Y, Stöck I, Gohlke P, Herdegen T, Culman J. Peroxisome proliferator-activated receptors (PPAR) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia. Eur J Neurosci 2008; 28: 1786-94
85. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral Interleukin-6 Is Neuroprotective During Permanent Focal Cerebral Ischemia in the Rat. J Cereb Blood Flow Metab 1998; 18: 176-9
86. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factoralpha expression in ischemic neurons. Stroke 1994; 25: 1481-8
87. Sairanen T, Carpén O, Karjalainen-Lindsberg ML, et al. Evolution of cerebral tumor necrosis factorproduction during human ischemic stroke. Stroke 2001; 32: 1750-8
88. Yang G-Y, Gong C, Qin Z, Ye W, Mao Y, Bertz AL. Inhibition of TNF attenuates infarct volume and ICAM 1 expression in ischemic mouse brain. Neuro Rep 1998; 9: 2131-4
89. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor: A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-44
90. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998; 251(3): 189-92
91. Liesz A, Bauer A, Hoheisel JD, Veltkamp R. Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: An experimental microarray study. Neurosci Lett 2014; 579: 6
92. Perez-de Puig I, Miro F, Salas-Perdomo A, et al. IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. J Cereb Blood Flow Metab 2013; 33: 1955-66
93. Dobolyi A, Vincze C, Pál G, Lovas G. The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci 2012; 13: 8219-58
94. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS. TGF signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflamm 2010; 7: 62-62
95. Zhu Y, Culmsee C, Roth-Eichhorn S, J K. 2-Adrenoceptor stimulation enhances latent transforming growth factor-binding protein-1 and transforming growth factor1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience 2001; 107(4): 593-602
96. Lehrmann E, Kiefer R, Christensen T, et al. Microglia and macrophages are major sources of locally produced transforming growth factor-1 after transient middle cerebral artery occlusion in rats. Glia 1998; 24: 437-48
97. Pang L, Ye W, Che X-M, Roessler BJ, Betz AL, Yang G-Y. Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor1 Expression. Stroke 2001; 32: 544-552
98. Pál G, Vincze C, Renner É, et al. Time Course, distribution and cell types of induction of transforming growth factor betas following middle cerebral artery occlusion in the rat brain. PLoS One 2012; 7(10): e46731
99. McNeill H, Williams C, Guan J, et al. Neuronal rescue with transforming growth factor-[beta]1 after hypoxic-ischaemic brain injury. NeuroReport 1994; 5: 901-4
100. Ruocco A, Nicole O, Docagne F, et al. A Transforming growth factor-[beta] antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 1999; 19: 1345-53
101. Hoffman G, Merchenthaler I, Zup S. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 2006; 29: 217-31
102. Díaz H, Lorenzo A, Carrer HF, Cáceres A. Time lapse study of neurite growth in hypothalamic dissociated neurons in culture: SEX differences and estrogen effects. J Neurosci Res 1992; 33: 266-81
103. Lenz KM, McCarthy MM. Organized for sex steroid hormones and the developing hypothalamus. Eur J Neurosci 2010; 32: 2096-104
104. Beyer C, Karolczak M. Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J Neurosci Res 2000; 59: 107-116
105. Tsutsui K. Biosynthesis and organizing action of neurosteroids in the developing Purkinje cell. Cerebellum 2006; 5: 89-96
106. Tsutsui K. Neurosteroid biosynthesis and action during cerebellar development. Cerebellum 2012; 11: 414-5
107. Bender RA, Zhou L, Wilkars W, et al. Roles of 17b-estradiol involve regulation of reelin expression and synaptogenesis in the dentate gyrus. Cerebral Cortex 2010; 20(12): 2985-95
108. Hu R, Cai WQ, Wu XG, Yang Z. Astrocyte-derived estrogen enhances synapse formation and synaptic transmission between cultured neonatal rat cortical neurons. Neuroscience 2007; 144: 1229-40
109. Arevalo MA, Ruiz-Palmero I, Scerbo MJ, et al. Molecular mechanisms involved in the regulation of neuritogenesis by estradiol: Recent advances. J Steroid Biochem Mol Biol 2012; 131: 52-6
110. Fester L, Zhou L, Bütow A, et al. Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus 2009; 19: 692-705
111. Kretz O, Fester L, Wehrenberg U, Zhou L, et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 2004; 24(26): 5913-21
112. Von Schassen C, Fester L, Prange-Kiel J, et al. Oestrogen synthesis in the hippocampus: Role in axon outgrowth. J Neuroendocrinol 2006; 18: 847-56
113. Roselli CF. Brain aromatase: Roles in reproduction and neuroprotection. J Steroid Biochem Mol Biol 2007; 106: 143-50
114. Hewitt SC, Li Y, Li L, Korach KS. Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements. J Biol Chem 2010; 285: 2676-85
115. Bulayeva NN, Wozniak AL, Lash LL, Watson CS. Mechanisms of membrane estrogen receptor-alpha-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Am J Physiol Endocrinol Metab 2005; 288: E388-97
116. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307: 1625-30
117. Koike S, Sakai M, Muramatsu M. Molecular cloning and charcterization of rat estrogen receptor cDNA. Nucleic Acids Res 1987; 15(6): 2499-513
118. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996; pp. 5925-30
119. Liu F, Day M, Muniz LC, Bitran D, et al. Activation of estrogen receptor-[beta]regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 2008; 11: 334-43
120. Shughrue P, Scrimo P, Lane M, Askew R, Merchenthaler I. The distribution of estrogen receptormrna in forebrain regions of the estrogen receptor-a knockout mouse. Endocrinology 1997; 138(12): 5649-52
121. Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor beta in the brain: From form to function. Brain Res Rev 2008; 57: 309-20
122. Handa RJ, Ogawa S, Wang JM, Herbison AE. Roles for oestrogen receptor in adult brain function. J Neuroendocrinol 2011; 24: 160-73
123. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ER and ER) throughout the rat brain: Anatomical evidence of distinct roles of each subtype. J Neurobiol 1998; 36: 357-78
124. Shughrue PJ, Merchenthaler I. Distribution of estrogen receptor immunoreactivity in the rat central nervous system. J Comp Neurol 2001; 436: 64-81
125. Zhang J-Q, Cai W-Q, Zhou D-S, Su B-Y. Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res 2002; 935: 73-80
126. Perez SE, Chen EY, Mufson EJ. Distribution of estrogen receptor alpha and beta immunoreactive profiles in the postnatal rat brain. Develop Brain Res 2003; 145: 117-39
127. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol 2008; 41: 263-75
128. Saunders PT. Oestrogen receptor beta (ER beta). Rev Reproduct 1998; 3(3): 164-71
129. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002; 346: 340-52
130. Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor b. Proc Natl Acad Sci USA 1998; 95(26): 15677-82
131. Krezel W, Dupont S, Krust A, Chambon P, Chapman PF. Increased anxiety and synaptic plasticity in estrogen receptor b-deficient mice. Proc Natl Acad Sci USA 2001; 98(21): 12278-82
132. Imwalle DB, Gustafsson J-Ãk, Rissman EF. Lack of functional estrogen receptor b influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005; 84: 157-63
133. Liang Y-Q, Akishita M, Kim S, et al. Estrogen receptor ß is involved in the anorectic action of estrogen. Int J Obesity 2002; 26 (8): 1103-9
134. Varea O, Arevalo M-A, Garrido JJ, Garcia-Segura LM, Wandosell F, Mendez P. Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 2010; 75: 565-9
135. Filardo EJ, Quinn JA, Frackelton AR, Jr., Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002; 16: 70-84
136. Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005; 16(8): 362-7
137. Prossnitz ER, Arterburn JB, Sklar LA. GPR30: A G proteincoupled receptor for estrogen. Mol Cell Endocrinol 2007; 265-266: 138-42
138. Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008; 70: 16590
139. Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146: 624-32
140. Qiu J, Bosch MA, Tobias SC, et al. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 2003; 23: 9529-40
141. Lebesgue D, Traub M, De Butte-Smith M, et al. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010; 5(1): e8642
142. Levin ER. Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 2001; 91(4): 1860-7
143. Mann V, Huber C, Kogianni G, Collins F, Noble B. The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro. Bone 2007; 40: 674-84
144. He J, Cheng Q, Xie W. Minireview: Nuclear receptor-controlled steroid hormone synthesis and metabolism. Mol Endocrinol 2010; 24: 11-21
145. Huang P, Chandra V, Rastinejad F. Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol 2010; 72: 247-72
146. Raz L, Khan MM, Mahesh VB, Vadlamudi RK, Brann DW. Rapid Estrogen Signaling in the Brain. Neurosignals 2008; 16: 140-53
147. Toran-Allerand CD, Guan X, MacLusky NJ, et al. ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 2002; 22(19): 8391-401
148. Singh M, Setalo G, Jr., Guan X, Warren M, Toran-Allerand CD. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 1999; 19: 1179-88
149. Honda K, Sawada H, Kihara T, et al. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 2000; 60: 321-7
150. Cordey M, Gundimeda U, Gopalakrishna R, Pike CJ. Estrogen activates protein kinase C in neurons: role in neuroprotection. J Neurochem 2003; 84: 1340-8
151. Mendez P, Azcoitia I, Garcia-Segura LM. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulinlike growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res 2003; 112(1-2): 170-6
152. Cardona-Gomez P, Perez M, Avila J, Garcia-Segura LM, Wandosell F. Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus. Mol Cell Neurosci 2004; 25: 363-73
153. Varea O, Escoll M, Diez H, Garrido JJ, Wandosell F. Oestradiol signalling through the Akt-mTORC1-S6K1. Biochim Biophys Acta 2013; 1833: 1052-64
154. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3Kinase/Akt cell survival pathway. J Biol Chem 1998; 273: 19929-32
155. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999; 19: 6385-93
156. Culmsee C, Vedder H, Ravati A, et al. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J Cereb Blood Flow Metab 1999; 19: 1263-9
157. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ. The neuroprotective effects of phytoestrogens on amyloid beta proteininduced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 2001; 276: 5287-95
158. Wise P. Estradiol exerts neuroprotective actions against ischemic brain injury: insights derived from animal models. Endocrine 2003; 21: 11-5
159. Yu X, Rajala RV, McGinnis JF, et al. Involvement of insulin/phosphoinositide 3-kinase/Akt signal pathway in 17 betaestradiol-mediated neuroprotection. J Biol Chem 2004; 279: 13086-94
160. Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 2001; 20: 27-39
161. Xu H, Gouras GK, Greenfield JP, et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998; 4: 447-51
162. Le Romancer M, Treilleux I, Bouchekioua-Bouzaghou K, Sentis S, Corbo L. Methylation, a key step for nongenomic estrogen signaling in breast tumors. Steroids 2010; 75: 560-4
163. Le Romancer M, Treilleux I, Leconte N, et al. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 2008; 31: 212-21
164. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and betacatenin signalling: diseases and therapies. Nat Rev Genet 2004; 5: 691-701
165. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-20
166. Jamora C, DasGupta R, Kocieniewski P, Fuchs E. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 2003; 422: 317-22
167. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6
168. Sansom OJ, Reed KR, van de Wetering M, et al. Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 2005; 280: 28463-7
169. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-7
170. Moon RT, DeMarais A, Olson DJ. Responses to Wnt signals in vertebrate embryos may involve changes in cell adhesion and cell movement. J Cell Sci Suppl 1993; 17: 183-8
171. Bienz M. beta-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol 2005; 15: R64-7
172. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC. Interaction of Nuclear Receptors with Wnt/{beta}-catenin/Tcf Signalling: Wnt you like to know? Endocr Rev 2005; 26(7): 898-915
173. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development and disease. Oncogene 2006; 25: 7492-504
174. Barolo S. Transgenic Wnt/TCF pathway reporters: all you need is Lef? Oncogene 2006; 25: 7505-11
175. Kouzmenko AP, Takeyama K, Ito S, et al. Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 2004; 279: 40255-8
176. Ray S, Xu F, Wang H, Das SK. Cooperative control via lymphoid enhancer factor 1/T cell factor 3 and estrogen receptor-alpha for uterine gene regulation by estrogen. Mol Endocrinol 2008; 22: 1125-40
177. Varea O, Garrido JJ, Dopazo A, Mendez P, Garcia-Segura LM, Wandosell F. Estradiol activates beta-catenin dependent transcription in neurons. PLoS One 2009; 4(4): e5153
178. Varea O, Arevalo MA, Garrido JJ, Garcia-Segura LM, Wandosell F, Mendez P. Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 2010; 75: 565-9
179. Zhang QG, Wang R, Khan M, Mahesh V, Brann DW. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci 2008; 28: 8430-41
180. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007; 148: 3236-45
181. Arevalo MA, Azcoitia I, Garcia-Segura LM. The neuroprotective actions of oestradiol and oestrogen receptors. Nat Rev Neurosci 2015; 16: 17-29
182. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 2002; 13: 35-43
183. Tsutsui K. Progesterone biosynthesis and action in the developing neuron. Endocrinology 2008; 149: 2757-61
184. Do Rego JL, Seong JY, Burel D, et al. Steroid biosynthesis within the frog brain: a model of neuroendocrine regulation. Ann N Y Acad Sci 2009; 1163: 83-92
185. Schumacher M, Mattern C, Ghoumari A, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog Neurobiol 2014; 113: 639
186. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogenregulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 1990; 9: 1603-14
187. Conneely OM, Maxwell BL, Toft DO, Schrader WT, O'Malley BW. The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem Biophys Res Commun 1987; 149: 493-501
188. Diaz-Brinton R, Thompson RF, Foy MR, et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2009; 29: 313-39
189. Hirata S, Shoda T, Kato J, Hoshi K. Novel isoforms of the mRNA for human female sex steroid hormone receptors. J Steroid Biochem Mol Biol 2002; 83: 25-30
190. Hirata S, Shoda T, Kato J, Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol Metab 2003; 14: 124-9
191. Losel R, Wehling M. Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 2003; 4: 46-56
192. Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BW. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 2003; 23: 3763-73
193. Mani S. Progestin receptor subtypes in the brain: the known and the unknown. Endocrinology 2008; 149: 2750-6
194. Mani K, O’Malley BW. Mechanism of Progesterone Receptor Action in the Brain. In: Pfaff DW, Arnold P, Etgen AM, Eds. Molecular Mechanisms of Hormone Actions on Behavior. Amsterdam: Academic Press 2009; pp. 375-411
195. Schumacher M, Guennoun R. Progesterone synthesis, Metabolism, Mechanisms of action, and effects in the nervous system. In: Pfaff DW, Arnold AP, Etgen AM. Eds. Molecular mechanisms of hormone actions on behavior. Amsterdam: Academic Press 2009; pp. 413-452
196. Xu J, Zeng C, Chu W, et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nat Commun 2011; 2: 380
197. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003; 100: 2237-42
198. Pang Y, Dong J, Thomas P. Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors delta and {epsilon} (mPRdelta and mPR{epsilon}) and mPRdelta involvement in neurosteroid inhibition of apoptosis. Endocrinology 2013; 154: 283-95
199. Meffre D, Labombarda F, Delespierre B, et al. Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury. Neuroscience 2013; 231: 111-24
200. Zuloaga DG, Yahn SL, Pang Y, et al. Distribution and estrogen regulation of membrane progesterone receptor-beta in the female rat brain. Endocrinology 2012; 153: 4432-43
201. Labombarda F, Meffre D, Delespierre B, et al. Membrane progesterone receptors localization in the mouse spinal cord. Neuroscience 2010; 166: 94-106
202. Labombarda F, Garcia-Ovejero D. Give progesterone a chance. Neural Regen Res 2014; 9: 1422-4
203. Thomas P, Pang Y, Dong J. Enhancement of cell surface expression and receptor functions of membrane progestin receptor alpha (mPRalpha) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. Endocrinology 2014; 155: 1107-19
204. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB. Progesterone regulates transcription of the p21(WAF1) cyclindependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 1998; 273: 10696-701
205. Stoecklin E, Wissler M, Schaetzle D, Pfitzner E, Groner B. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J Steroid Biochem Mol Biol 1999; 69: 195-204
206. Cicatiello L, Addeo R, Sasso A, et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol Cell Biol 2004; 24: 7260-74
207. Aupperlee MD, Haslam SZ. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 2007; 148: 2290-300
208. Brayman MJ, Julian J, Mulac-Jericevic B, Conneely OM, Edwards DP, Carson DD. Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. Mol Endocrinol 2006; 20: 2278-91
209. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol 2007; 21: 359-75
210. Boonyaratanakornkit V, Edwards DP. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med 2007; 25: 139-53
211. Torrejon M, Echeverria V, Retamales G, Herrera L, Hinrichs M, Olate J. Molecular cloning and expression of an adenylyl cyclase from Xenopus laevis oocytes. FEBS Lett 1997; 404: 91-94
212. Boonyaratanakornkit V, Scott MP, Ribon V, et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 2001; 8: 269-80
213. Migliaccio A, Piccolo D, Castoria G, et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998; 17: 2008-18
214. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003; 100: 2231-6
215. Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol 2008; 29: 292-312
216. Nilsen J, Brinton RD. Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 2002; 13: 825-30
217. Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA 2003; 100: 10506-11
218. Engmann L, Losel R, Wehling M, Peluso JJ. Progesterone regulation of human granulosa/luteal cell viability by an RU486independent mechanism. J Clin Endocrinol Metab 2006; 91: 49628
219. Semyanov A, Walker MC, Kullmann DM, Silver RA. Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 2004; 27: 262-9
220. Alldred MJ, Mulder-Rosi J, Lingenfelter SE, Chen G, Luscher B. Distinct gamma2 subunit domains mediate clustering and synaptic function of postsynaptic GABAA receptors and gephyrin. J Neurosci 2005; 25: 594-603
221. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005; 6: 215-29
222. Belelli D, Herd MB, Mitchell EA, et al. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 2006; 138: 821-9
223. Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 2006; 444: 486-9
224. Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol 2009; 30: 142-57
225. Schreihofer DA, Ma Y. Estrogen receptors and ischemic neuroprotection: Who, what, where and when? Brain Res 2013; 1514: 107-22
226. Simpkins JW, Wen Y, Perez E, Yang S, Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Ann N Y Acad Sci 2005; 1052: 233-42
227. Merchenthaler I, Dellovade TL, Shughrue PJ. Neuroprotection by Estrogen in Animal Models of Global and Focal Ischemia. Ann New York Acad Sci 2003; 1007: 89-100
228. Perez-Alvarez MJ, Maza Mdel C, Anton M, Ordonez L, Wandosell F. Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. J Neuroinflamm 2012; 9: 157
229. Dye RV, Miller KJ, Singer EJ, Levine AJ. Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis 2012; (2012) ID: 258454
230. Henderson VW, Brinton RD. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Prog Brain Res 2010; 182: 77-96
231. Azcoitia I, Arevalo MA, De Nicola AF, LM G-S. Neuroprotective actions of estradiol revisited. Trends Endocrinol Metabol 2011; 22(12): 467-73
232. Rebenko-Moll NM, Liu L, Cardona A, Ransohoff RM. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr Opin Immunol 2006; 18: 683-9
233. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006; 147(5): 2263-72
234. Vegeto E, Benedusi V, Maggi A. Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008; 29: 507-19
235. Baker AE, Brautigam VM, Watters JJ. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor b. Endocrinology 2004; 145(11): 5021-32
236. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000; 141(10): 3646-56
237. Vegeto E, Bonincontro C, Pollio G, et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 21(6): 1809-18
238. Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005; 1049 (1): 112-9
239. Smith SS. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience 1991; 42: 309-20
240. Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 1997; 31: 1-11
241. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008; 149: 3167-75
242. De Nicola AF, Gonzalez SL, Labombarda F, Deniselle MC, Garay L, Guennoun R. Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination. J Mol Neurosci 2006; 28: 3-15
243. Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 2009; 175: 219-37
244. Guennoun R, Labombarda F, Gonzalez Deniselle MC, Liere P, De Nicola AF, Schumacher M. Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection. J Steroid Biochem Mol Biol 2015; 146C: 48-61
245. Wright DW, Kellermann AL, Hertzberg VS, Clark PL, Frankel M, Goldstein FC. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007; 49: 391-402
246. Skolnick BE, Maas AI, Narayan RK, et al. A Clinical Trial of Progesterone for Severe Traumatic Brain Injury. New Engl J Med 2014; 371: 2467-76
247. Wright DW, Yeatts SD, Silbergleit R, et al. Very early administration of progesterone for acute traumatic brain injury. New Engl J Med 2014; 371: 2457-66
248. Leonelli E, Bianchi R, Cavaletti G, et al. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007; 144: 1293-304
249. Wharton W, Baker LD, Gleason CE, et al. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J Alzheimers Dis 2011; 26: 495-505
250. Shao H, Breitner JC, Whitmer RA, Wang J, et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology 2012; 79: 1846-52
251. Maki PM. Minireview: effects of different HT formulations on cognition. Endocrinology 2012; 153: 3564-70
252. Perez-Alvarez MJ, Mateos L, Alonso A, Wandosell F. estradiol and progesterone administration after pMCAO stimulates the neurological recovery and reduces the detrimental effect of ischemia mainly in hippocampus. Mol Neurobiol 2015; 52(3): 1690-703
253. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics2012 update a report from the american heart association. Circulation 2012; pp. e3-e218
254. Scott E, Zhang Q-g, Wang R, Vadlamudi R, Brann D. Estrogen neuroprotection and the critical period hypothesis. Front Neuroendocrinol 2012; 33: 85-104
255. Alkayed N, Harukuni I, Kimes A, London E, Traystman R, Hurn P. Gender-linked brain injury in experimental stroke. Stroke 1998; 29: 159-65
256. Rusa R, Alkayed NJ, Crain BJ, et al. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke 1999; 30: 1665-70
257. Inagaki T, Etgen AM. Neuroprotective action of acute estrogens: Animal models of brain ischemia and clinical implications. Steroids 2013; 78: 597-606
258. Sawada M, Alkayed NJ, Goto S, et al. Estrogen receptor antagonist ICI182, 780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 2000; 20: 112-8
259. Liao S, Chen W, Kuo J, Chen C. Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci Lett 2001; 297: 159-62
260. Dubal DB, Kashon ML, Pettigrew LC, et al. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18: 1253-8
261. Toung TJK, Traystman RJ, Hurn PD. Estrogen-Mediated Neuroprotection After Experimental Stroke in Male Rats. Stroke 1998; 26: 1666-70
262. Carswell HVO, Dominiczak AF, Garcia-Segura LM, Harada N, Hutchison JB, Macrae IM. Brain aromatase expression after experimental stroke: Topography and time course. J Steroid Biochem Mol Biol 2005; 96: 89-91
263. McCullough LD, Blizzard K, Simpson ER, Oz OK, Hurn PD. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J Neurosci 2003; 23: 8701-5
264. Weaver CE, Park-Chung M, Gibbs TT, Farb DH. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 1997; 761: 338-41
265. Singer CA, Rogers KL, Strickland TM, Dorsa DM. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996; 212: 13-6
266. Connell BJ, Crosby KM, Richard MJ, Mayne MB, Saleh TM. Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation. Neuroscience 2007; 146: 160-9
267. Connell BJ, Saleh TM. Differential neuroprotection of selective estrogen receptor agonists against autonomic dysfunction and ischemic cell death in permanent versus reperfusion injury. Adv Pharmacol Sci 2011; 2011: 976951-9
268. Chen H, Yoshioka H, Kim GS, et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 2011; 14: 150-517
269. Suh SW, Shin BS, Ma H, et al. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 2008; 64: 654-63
270. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999; 19(15): 6385-93
271. Rau SW, Dubal DB, Böttner M, Gerhold LM, Wise PM. Estradiol attenuates programmed cell death after stroke-like injury. J Neurosci 2003; 23: 11420-26
272. Jia J, Guan D, Zhu W, et al. Estrogen inhibits Fas-mediated apoptosis in experimental stroke. Exp Neurol 2009; 215: 5
273. Brann D, Raz L, Wang R, Vadlamudi R, Zhang Q. Oestrogen signalling and neuroprotection in cerebral ischaemia. J Neuroendocrinol 2012; 24: 34-47
274. Jover-Mengual T, Zukin RS, Etgen AM. MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology 2007; 148: 1131-43
275. Koh PO. Estradiol prevents the injury-induced decrease of 90 ribosomal S6 kinase (p90RSK) and Bad phosphorylation. Neurosci Lett 2007; 412: 68-72
276. De Butte-Smith M, Zukin RS, Etgen AM. Effects of global ischemia and estradiol pretreatment on phosphorylation of Akt, CREB and STAT3 in hippocampal CA1 of young and middle-aged female rats. Brain Res 2012; 1471: 118-28
277. Sawe N, Steinberg G, Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 2008; 86: 165-969
278. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 1998; 273: 19929-32
279. Parcellier A, Tintignac LA, Zhuravleva E, Hemmings BA. PKB and the mitochondria: AKTing on apoptosis. Cell Signal 2008; 20: 21-30
280. Farr TD, Carswell HV, Gsell W, Macrae IM. Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res 2007; 1185: 275-82
281. Connell BJ, Saleh TM. Differential neuroprotection of selective estrogen receptor agonists against autonomic dysfunction and ischemic cell death in permanent versus reperfusion injury. Adv Pharmacol Sci 2011; 2011: 976-951
282. Dubal DB, Zhu H, Yu J, et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 2001; 98: 1952-7
283. Dubal DB, Rau SW, Shughrue PJ, et al. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006; 147: 3076-84
284. Zhao L, Brinton RD. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 2007; 1172: 48-59
285. Zhang B, Subramanian S, Dziennis S, et al. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J Immunol 2010; 184: 4087-94
286. Dhandapani KM, Wade FM, Mahesh VB, Brann DW. Astrocytederived transforming growth factor-{beta} mediates the neuroprotective effects of 17{beta}-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 2005; 146: 2749-59
287. Arevalo MA, Santos-Galindo M, Acaz-Fonseca E, Azcoitia I, Garcia-Segura LM. Gonadal hormones and the control of reactive gliosis. Horm Behav 2013; 63: 216-21
288. Chiappetta O, Gliozzi M, Siviglia E, et al. Evidence to implicate early modulation of interleukin 1 expression in the neuroprotection afforded by 17 Estradiol in male rats undergone transient middle cerebral artery occlusion. In: Giacinto Bagetta MTC, Stuart AL, Eds. International Review of Neurobiology. USA: Academic Press 2007; pp. 357-372
289. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA 2007; 104: 6013-8
290. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J Neuroimmunol 2000; 111: 77-85
291. Roof RL, Stein DG. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor Neurol Neurosci 1992; 4: 425-7
292. Wright DW, Bauer ME, Hoffman SW, Stein DG. Serum progesterone levels correlatewith decreased cerebral edema aftertraumatic brain injury in male rats. J Neurotrauma 2001; 18: 901-9
293. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004; 189: 404-12
294. VanLandingham JW, Cekic M, Cutler S, Hoffman SW, Stein DG. Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci Lett 2007; 425: 94-8
295. Gibson CL, Constantin D, Prior MJW, Bath PMW, Murphy SP. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 2005; 193: 522-30
296. Anderson GD, Farin FM, Bammler TK, Beyer RP, Swan AA, Wilkerson HW. The effect of progesterone dose on gene expression after traumatic brain injury. J Neurotrauma 2011; 28: 1827-43
297. Shen H, Gong QH, Yuan M, Smith SS. Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 2005; 49: 573-86
298. Limmroth V, Lee WS, Moskowitz MA. GABAA-receptormediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol 1996; 117: 99-104
299. Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000; 17: 367-88
300. Dang J, Mitkari B, Kipp M, Beyer C. Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 2011; 25: 715-26
301. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG. Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 2012; 210: 442-50